This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEB59082_M.jpg
Moreover, the industry is expected to grow going forward as the population ages and chronic diseases rise. According to a LINCHPIN report, the pharmaceutical industry is expected to increase to $1.5 trillion by 2023.
Therefore, we think dividend-paying quality pharmaceutical stocks Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (MRK), and Bristol-Myers Squibb Company (NYSE:BMY) could be solid additions to one’s portfolio to secure a steady income stream. They each have an overall Strong Buy rating in our POWR Ratings system.
